Electrolyte Blood Press.  2013 Jun;11(1):9-16. 10.5049/EBP.2013.11.1.9.

Potassium Balances in Maintenance Hemodialysis

• Choi HY
• Ha SK

• KMID: 2168395
• DOI: http://doi.org/10.5049/EBP.2013.11.1.9

Abstract

Potassium is abundant in the ICF compartment in the body and its excretion primarily depends on renal (about 90%), and to a lesser extent (about 10%) on colonic excretion. Total body potassium approximated to 50mmol/kg body weight and 2% of total body potassium is in the ECF compartment and 98% of it in the intracellular compartment.Dyskalemia is a frequent electrolyte imbalance observed among the maintenance hemodialysis patients. In case of hyperkalemia, it is frequently "a silent and a potential life threatening electrolyte imbalance" among patients with ESRD under maintenance hemodialysis. The prevalence of hyperkalemia in maintenance HD patients was reported to be about 8.7-10%. Mortality related to the hyperkalemia has been shown to be about 3.1/1,000 patient-years and about 24% of patients with HD required emergency hemodialysis due to severe hyperkalemia. In contrast to the hyperkalemia, much less attention has been paid to the hypokalemia in hemodialysis patients because of the low prevalence under maintenance hemodialysis patients. Severe hypokalemia in the hemodialysis patients usually was resulted from low potassium intake (malnutrition), chronic diarrhea, mineralocorticoid use, and imprudent use of K-exchange resins. Recently, the numbers of the new patients with advanced chronic kidney disease undergoing maintenance hemodialysis are tremendously increasing worldwide. However, the life expectancy of these patients is still much lower than that of the general population. The causes of excess mortality in these patients seem to various, but dyskalemia is a common cause among the patients with ESRD undergoing hemodialysis.

Keyword

Potassium; Balance; Hemodialysis

MeSH Terms

Body Weight
Colon
Diarrhea
Emergencies
Humans
Hyperkalemia
Hypokalemia
Kidney Failure, Chronic
Life Expectancy
Potassium
Prevalence
Renal Dialysis
Renal Insufficiency, Chronic
Potassium

Reference

1. Putcha N, Allon M. Management of Hyperkalemia in Dialysis Patients. Semin Dial. 2007; 20:431–439. PMID: 17897250.

2. Greenberg A. Hyperkalemia: Treatment options. Semin Nephrol. 1998; 18:46–57. PMID: 9459288.

3. Gennari FJ. Disorders of potassium homeostasis: Hypokalemia and Hyperkalemia. Crit Care Clin. 2002; 18:273–288. PMID: 12053834.

4. Khedr E, Abdelwhab S, El-Sharkay M, Ali M, El Said K. Prevalence of hyperkalemia among hemodialysis patients in Egypt. Renal Failure. 2009; 31:891–898. PMID: 20030523.

5. Tzamaloukas AH, Avasthi PS. Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis. Am J Nephrol. 1987; 7:101–109. PMID: 3605230.

6. Weiner ID, Wingo CS. Hyperkalemia: A. Potential Silent Killer. J Am Soc Nephrol. 1998; 9:1535–1543. PMID: 9697678.

7. Abe S, Yoshizawa M, Nakanishi N, et al. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J. 1996; 131:1137–1144. PMID: 8644592.

8. Hoskote SS, Joshi SR, Ghosh AK. Disorders of potassium homeostasis: Pathophysiology and management. JAPI. 2008; 56:685–725. PMID: 19086355.

9. Evans KJ, Greenberg A. Hyperkalemia: A Review. J Intensive Care Med. 2005; 20:272–290. PMID: 16145218.

10. Palmer LG, Frindt G. Aldosterone and potassium secretion by the cortical collecting duct. Kidney Int. 2000; 57:1324–1328. PMID: 10760062.

11. Young DB, Smith MJ Jr, Jackson TE, Scott RE. Multiplicative interaction between angiotensin II and K concentration in stimulation of aldosterone. Am J Physiol. 1984; 247:E328–E345. PMID: 6476112.

12. Bastl CP, Hayslett JP. The cellular action of aldosterone in target epithelia. Kidney Int. 1992; 42:250. PMID: 1405311.

13. Martin RS, Panese S, Virginillo M, et al. Increased secretion of potassium in the rectum of man with chronic renal failure. Am J Kidney Dis. 1986; 8:105–110. PMID: 3740056.

14. Sandle GI, Tapster S, Goodship TH. Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long-term dialysis. Clin Sci (Lond). 1987; 73:247–252. PMID: 3652631.

15. Clausen T, Everts ME. Regulation of the Na-K-pump in skeletal muscle. Kidney Int. 1989; 35:1–13. PMID: 2540370.

16. Allon M, Dansby L, Shanklin N. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease. Am J Med. 1993; 94:475–482. PMID: 8498392.

17. Allon M, Takeshian A, Sanklin N. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia. Kidney Int. 1993; 43:212–217. PMID: 8433561.

18. Blumberg A, Weidmann P, Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int. 1992; 41:369–374. PMID: 1552710.

19. Kim HJ. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron. 1996; 72:476–482. PMID: 8852501.

20. Ahmed J, Weisberg LS. Hyperkalemia in dialysis patients. Semin Dial. 2001; 14:348–356. PMID: 11679104.

21. Kaisar MO, Wiggins KJ, Sturtevant JM, et al. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients. Am J Kidney Dis. 2006; 47:809–814. PMID: 16632019.

22. Massry SG. Renal failure, parathyroid hormone and extrarenal disposal of potassium. Miner Electrolyte Metab. 1990; 16:77–81. PMID: 2182997.

23. Goldfarb S, Cox M, Singer I, Goldberg M. Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms. Ann Intern Med. 1976; 84:426–432. PMID: 769633.

24. Moreno M, Murphy C, Goldsmith C. Increase in serum potassium resulting from the administration of hypertonic mannitol and other solutions. J Lab Clin Med. 1969; 73:291–298. PMID: 5764025.

25. Clark BA, Shannon C, Brown RS, Gervino EV. Extrarenal potassium homeostasis with maximal exercise in end-stage renal disease. J Am Soc Nephrol. 1996; 7:1223–1227. PMID: 8866416.

26. Sweet SJ, McCarthy S, Steingart R, Callahan T. Hemolytic reactions mechanically induced by kinked hemodialysis lines. Am J Kidney Dis. 1996; 27:262–266. PMID: 8659503.

27. Kim HJ. Pathogenesis and treatment of dyskalemia in maintenance hemodialysis and CAPD. Electrolyte Blood Press. 2006; 4:47–52.

28. Kupin WL, Narins RG. The hyperkalemia of renal failure: Pathophysiology, diagnosis and therapy. Contrib Nephrol. 1993; 102:1–22. PMID: 8416175.

29. DeFronzo RA. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int. 1980; 17:118–134. PMID: 6990088.

30. Buckley MS, Leblanc JM, Cawley MJ. Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit. Crit Care Med. 2010; 38:S253–S264. PMID: 20502178.

31. Burnell JM, Scribner BH, Uyeno BT, Villamil MF. The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium. J Clin Invest. 1956; 35:935–939. PMID: 13367188.

32. Adrogue HJ, Madias NE. Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med. 1981; 71:456–467. PMID: 7025622.

33. Goldfarb S, Cox M, Singer I, Goldberg M. Acute hyperkalemia induced by hyperglycemia: Hormonal mechanisms. Ann Intern Med. 1976; 84:426–432. PMID: 769633.

34. Arrizabalaga P, Montoliu J, Martinez Vea A. Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: Absence of mediation by insulin or aldosterone. Proc Eur Dial Transplant Assoc. 1983; 20:572–576. PMID: 6318223.

35. Gronert GA. Succinylcholine-induced hyperkalemia and beyond.1975. Anesthesiology. 2009; 111:1372–1377. PMID: 19934884.

36. Josephson GW. Digoxin intoxication and hyperkalemia. JAMA. 1980; 244:1557–1558. PMID: 7420649.

37. Rees SM, Nelson LN. Digoxin, hyperkalemia, and kidney failure. Ann Emerg Med. 1997; 29:694–695. PMID: 9140260.

38. Parham WA, Mehdirad AA, Biermann KM, Freman CS. Hyperkalemia Revisited. Tex Heart Inst J. 2006; 33:40–47. PMID: 16572868.

39. Szerlip HM, Weiss J, Singer I. Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis. 1986; 7:461–465. PMID: 3717152.

40. Dodge HT, Grant RP, Seavey PW. The effect of induced hyperkalemia on the normal and abnormal electrocardiogram. Am Heart J. 1953; 45:725–740. PMID: 13040269.

41. Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008; 36:3246–3251. PMID: 18936701.

42. Sterns RH, Rojas M, Bernstein P, Chennupati S. Ion-Exchange Resins for the Treatment of Hyperkalemia: Are they Safe and Effective? J Am Soc Nephrol. 2010; 21:733–735. PMID: 20167700.

43. Musso CG. Potassium metabolism in patients with chronic kidney disease. Part II: Patients on dialysis (stage 5). Int Urol Nephrol. 2004; 36:469–472. PMID: 15783126.

44. Hwang SH, Kim HJ. Distribution of serum potassium concentration and analysis of associated factors with hyperkalemia in chronic hemodialysis patients. Korean J Med. 1996; 50(1):87–93.

45. Hwang J-C, Wang C-T, Chen C-A, Chen H-C. Hypokalemia is associated with increased mortality rate in chronic hemodialysis patients. Blood Purif. 2011; 32:254–261. PMID: 21849775.

46. Podrid PJ. Potassium and ventricular arrhythmias. Am J Cardiol. 1990; 65:33E–44E.

47. Hayes J, Kalantar-Zadeh K, Lu JL, Turban S, Anderson JE, Kovesdy CP. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin Pract. 2012; 120:c8–c16. PMID: 22156587.

48. Gennari FJ. Hypokalemia. New Engl J Med. 1998; 339:451–458. PMID: 9700180.